Why the study?
Does Interleukin-10 treatment attenuate pressure overload-induced hypertrophic remodeling and improve heart function?
Does Interleukin-10 treatment attenuate pressure overload-induced hypertrophic remodeling and improve heart function?
IL-10 treatment may serve as a potential therapeutic approach to limit the progression of pressure overload-induced adverse cardiac remodeling.
No takes yet. Share an insight, caveat, or question.
IL-10 may limit pressure-overload remodeling in animals; leaves open translation to human HF trials.
Verma et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: